صفحه 1 از جانب 32 نتایج
This invention relates to a novel class of compounds. In addition it relates to a class of compounds useful in the treatment of inflammation, which also exhibit potent analgesic and antipyretic activity. Connected with their antiinflammatory activity, novel compounds are also platelet aggregation
This invention relates to new phenylacetic acid derivatives, to a process for their preparation and to their therapeutic applications.
The present invention relates to new phenylacetic acid derivatives having the general formula: ##SPC2##
In which R.sub.1 represents a lower alkyl radical, a lower
BACKGROUND OF THE INVENTION
1. Field of Invention
The present invention relates to certain novel 2-amino-3-benzoylphenylacetic acids having alkylthio substitution on the benzoyl moiety, their alkylesters and metal salts, pharmaceutical compositions and uses thereof and certain intermediates for the
The present invention relates to novel 4-(2'-pyridylamino)phenylacetic acid derivatives having anti-inflammatory and analgesic activities, a process for the preparation thereof, a method of using the same and compositions thereof.
It is disclosed in U.S. Pat. No. 3,766,260 that the compounds of the
BACKGROUND OF THE INVENTION
This invention relates to a method and compositions useful in treating both internal and external eye inflammations. Specifically, this invention relates to methods and compositions which use certain nonsteroidal anti-inflammatory drugs to control internal and external
TECHNICAL FIELD
The present invention relates to an aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid or a pharmacologically acceptable salt thereof or a hydrate thereof. More particularly, the present invention relates to an aqueous liquid preparation containing
This application is a U.S. national stage of International Application No. PCT/JP2004/000350 filed Jan. 16, 2004.
TECHNICAL FIELD
The present invention relates to an aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid or a pharmacologically acceptable salt thereof or a
TECHNICAL FIELD
The present invention relates to an aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid or a pharmacologically acceptable salt thereof or a hydrate thereof. More particularly, the present invention relates to an aqueous liquid preparation containing
TECHNICAL FIELD
The present invention relates to an aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid or a pharmacologically acceptable salt thereof or a hydrate thereof. More particularly, the present invention relates to an aqueous liquid preparation containing
TECHNICAL FIELD
The present invention relates to an aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid or a pharmacologically acceptable salt thereof or a hydrate thereof. More particularly, the present invention relates to an aqueous liquid preparation containing
TECHNICAL FIELD
The present invention relates to an aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid or a pharmacologically acceptable salt thereof or a hydrate thereof. More particularly, the present invention relates to an aqueous liquid preparation containing
TECHNICAL FIELD
The present invention relates to an aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid or a pharmacologically acceptable salt thereof or a hydrate thereof. More particularly, the present invention relates to an aqueous liquid preparation containing
TECHNICAL FIELD
The present invention relates to an aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid or a pharmacologically acceptable salt thereof or a hydrate thereof. More particularly, the present invention relates to an aqueous liquid preparation containing
BACKGROUND OF THE PRESENT INVENTION
A great number of substances for the effective treatment of inflammatory illnesses, for example rheumatism, have been known for a long time. Since the inflammations are often chronic, the treatment with such inflammation-preventing active substances will usually
BACKGROUND OF THE PRESENT INVENTION
A great number of substances for the effective treatment of inflammatory illnesses, for example rheumatism, have been known for a long time. Since the inflammations are often chronic, the treatment with such inflammation-preventing active substances will usually